Medication Mechanism of Action Average Weight Loss Retatrutide Triple agonist (GLP-1, GIP, Glucagon) Up to 24% average weight loss over 48 weeks Semaglutide GLP-1 receptor agonist Up to 17% over 68 weeks Tirzepatide Dual agonist (GLP-1, GIP) Up to 25% over 52 weeks Retatrutide is used to help with weight loss
Pero los medicamentos entre ellos los que se venden bajo las marcas Ozempic, Wegovy, Mounjaro y Zepbound pueden venir con algunos efectos secundarios incmodos y potencialmente riesgosos, como nuseas, diarrea, vmitos, estreimiento y deshidratacin, as como prdida de densidad sea y masa muscular
If there are side effects, stop treatment and re-evaluate
Weight loss indications often face insurance coverage challenges
Personalized Plans: Tailored to your specific needs and health goals
While usually painless long-term, they can become uncomfortable if needles repeatedly strike them during future injections